Scarica l'app Stockscreener
14.91
1.34%
-0.22
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RLAY Giù?
Forum
Previsione
Precedente Chiudi:
$15.13
Aprire:
$14.86
Volume 24 ore:
843.12K
Relative Volume:
0.31
Capitalizzazione di mercato:
$2.66B
Reddito:
$15.36M
Utile/perdita netta:
$-276.48M
Rapporto P/E:
-9.2442
EPS:
-1.6129
Flusso di cassa netto:
$-235.87M
1 W Prestazione:
-8.98%
1M Prestazione:
+55.49%
6M Prestazione:
+102.26%
1 anno Prestazione:
+366.46%
Intervallo 1D:
$14.80
$15.40
Intervallo di 1 settimana:
$14.68
$17.15
Portata 52W:
$2.6701
$17.32
Relay Therapeutics Inc Stock (RLAY) Company Profile
Nome
Relay Therapeutics Inc
Settore
Industria
Telefono
617-370-8837
Indirizzo
60 HAMPSHIRE STREET, CAMBRIDGE
Compare RLAY vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
14.91 | 2.70B | 15.36M | -276.48M | -235.87M | -1.6129 |
VRTX
Vertex Pharmaceuticals Inc
|
430.84 | 109.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.22 | 79.46B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
793.92 | 48.52B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
310.97 | 40.77B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
301.27 | 33.39B | 5.36B | 287.73M | 924.18M | 2.5229 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-26 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-12-12 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-09-04 | Ripresa | Guggenheim | Buy |
| 2025-04-17 | Iniziato | Wells Fargo | Equal Weight |
| 2024-09-10 | Ripresa | Goldman | Buy |
| 2024-09-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-09-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-05-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-04-20 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-04-19 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | Iniziato | Raymond James | Outperform |
| 2023-02-03 | Iniziato | Oppenheimer | Outperform |
| 2022-09-30 | Iniziato | Barclays | Equal Weight |
| 2022-09-02 | Iniziato | Stifel | Buy |
| 2022-06-06 | Iniziato | Jefferies | Underperform |
| 2022-02-01 | Iniziato | Berenberg | Buy |
| 2021-07-21 | Iniziato | BofA Securities | Buy |
| 2020-12-15 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-11-05 | Iniziato | H.C. Wainwright | Buy |
| 2020-08-10 | Iniziato | Cowen | Outperform |
| 2020-08-10 | Iniziato | Goldman | Buy |
| 2020-08-10 | Iniziato | Guggenheim | Buy |
| 2020-08-10 | Iniziato | JP Morgan | Neutral |
Mostra tutto
Relay Therapeutics Inc Borsa (RLAY) Ultime notizie
Breast cancer combo posts 44% response in pretreated patients - Stock Titan
Relay Therapeutics Announces Clinical Data for Zovegalisib - GlobeNewswire
Relay Therapeutics (RLAY) surges 16.4%: Is this an indication of further gains? - MSN
Industry Analysts Just Upgraded Their Relay Therapeutics, Inc. (NASDAQ:RLAY) Revenue Forecasts By 57% - Moomoo
RLAY SEC FilingsRelay Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
RLAY PE Ratio & Valuation, Is RLAY Overvalued - Intellectia AI
Relay Therapeutics (RLAY) Stock: Is It a Good Buy | Q4 2025: EPS Beats ForecastsReal-time Trade Ideas - UBND thành phố Hải Phòng
Is Relay Therapeutics (RLAY) stock strengthening its trend | Q4 2025: EPS Beats ForecastsCommunity Buy Alerts - Cổng thông tin điện tử Tỉnh Sơn La
JonesResearch Initiates Coverage of Relay Therapeutics with Hold Rating - HarianBasis.co
Relay Therapeutics (RLAY) climbs 16% ahead of cancer treatment update - MSN
Is Relay Therapeutics (RLAY) stock gaining momentum (Mini Selloff) 2026-04-20Fast Moving Stocks - Xã Vĩnh Công
JonesResearch Initiates Coverage of Relay Therapeutics (RLAY) With a Hold Rating - Insider Monkey
Relay Therapeutics (RLAY) Stock: Stability Assessment (Buying Pressure) 2026-04-18Intraday Trading - Cổng thông tin điện tử Tỉnh Sơn La
5 Best Low Priced Biotech Stocks to Invest In - Insider Monkey
Tudor Investment Corp ET AL Acquires New Shares in Relay Therapeutics, Inc. $RLAY - MarketBeat
PERCEPTIVE ADVISORS LLC Significantly Reduces Stake in Relay The - GuruFocus
[PRE 14A] Relay Therapeutics, Inc. Preliminary Proxy Statement - Stock Titan
Jones Trading initiates coverage of Relay Therapeutics (RLAY) with hold recommendation - MSN
Relay Therapeutics (NASDAQ:RLAY) Sets New 1-Year HighShould You Buy? - MarketBeat
RLAY Initiated Coverage by Jones Trading -- Rating Set to Hold - GuruFocus
JonesTrading Initiates Coverage on Relay Therapeutics (NASDAQ:RLAY) - MarketBeat
Perceptive Fund (RLAY) reports 9.99% ownership — 438,471 shares - Stock Titan
Will Relay Therapeutics (RLAY) Stock Recover Soon | Price at $15.21, Up 1.81%Price Target - UBND thành phố Hải Phòng
Relay Therapeutics CFO Sells $27,000 in Stock - National Today
Relay Therapeutics CFO Sells $27,000 in Shares - National Today
Relay Therapeutics stock hits 52-week high at 14.98 USD By Investing.com - Investing.com Canada
Relay Therapeutics Hits New 52-Week High After Analyst Upgrade - National Today
Earnings Recap: Will Relay Therapeutics Inc benefit from green energy policies2026 Action & Reliable Entry Point Alerts - baoquankhu1.vn
Catinazzo, Relay Therapeutics CFO, sells $257k in RLAY stock By Investing.com - Investing.com Australia
Catinazzo, Relay Therapeutics CFO, sells $257k in RLAY stock - Investing.com
Thomas Catinazzo Sells 1,800 Shares of Relay Therapeutics (NASDAQ:RLAY) Stock - MarketBeat
Relay Therapeutics (NASDAQ: RLAY) CFO logs 19,517-share sale under 10b5-1 plan - Stock Titan
Rally Mode: Will Relay Therapeutics Inc benefit from government policyRate Cut & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Relay Therapeutics stock hits 52-week high at 14.98 USD - Investing.com
Relay Therapeutics (NASDAQ:RLAY) CFO Sells $230,498.17 in Stock - MarketBeat
Barclays Raises Price Target for Relay Therapeutics (RLAY) to $2 - GuruFocus
Relay Therapeutics Inc Azioni (RLAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Relay Therapeutics Inc Azioni (RLAY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas | Chief Financial Officer |
Apr 07 '26 |
Sale |
13.01 |
17,717 |
230,498 |
213,867 |
| Catinazzo Thomas | Chief Financial Officer |
Apr 09 '26 |
Sale |
15.00 |
1,800 |
27,000 |
213,867 |
| Catinazzo Thomas | Chief Financial Officer |
Mar 09 '26 |
Sale |
10.06 |
17,717 |
178,233 |
231,584 |
0.03%
0.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):